These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2666251)

  • 1. Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study.
    Mandel JS; Bond JH; Bradley M; Snover DC; Church TR; Williams S; Watt G; Schuman LM; Ederer F; Gilbertsen V
    Gastroenterology; 1989 Sep; 97(3):597-600. PubMed ID: 2666251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal occult blood screening in the Minnesota study: sensitivity of the screening test.
    Church TR; Ederer F; Mandel JS
    J Natl Cancer Inst; 1997 Oct; 89(19):1440-8. PubMed ID: 9326913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interval cancers in screening with fecal occult blood test for colorectal cancer.
    Jensen BM; Kronborg O; Fenger C
    Scand J Gastroenterol; 1992 Sep; 27(9):779-82. PubMed ID: 1411286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler B; Irwig L; Glasziou P; Kewenter J; Weller D; Silagy C
    BMJ; 1998 Aug; 317(7158):559-65. PubMed ID: 9721111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.
    Macrae FA; St John DJ
    Gastroenterology; 1982 May; 82(5 Pt 1):891-8. PubMed ID: 7060910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the sensitivity of fecal occult blood test screening for colorectal cancer.
    Lang CA; Ransohoff DF
    J Natl Cancer Inst; 1997 Oct; 89(19):1392-3. PubMed ID: 9326904
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of systematic false-negative test results on the performance of faecal occult blood screening.
    Loeve F; Boer R; van Oortmarssen GJ; van Ballegooijen M; Habbema JD
    Eur J Cancer; 2001 May; 37(7):912-7. PubMed ID: 11313180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.
    Castiglione G; Zappa M; Grazzini G; Mazzotta A; Biagini M; Salvadori P; Ciatto S
    Br J Cancer; 1996 Jul; 74(1):141-4. PubMed ID: 8679448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
    Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
    Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy?
    Lang CA; Ransohoff DF
    JAMA; 1994 Apr; 271(13):1011-3. PubMed ID: 8139058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
    Mandel JS; Church TR; Ederer F; Bond JH
    J Natl Cancer Inst; 1999 Mar; 91(5):434-7. PubMed ID: 10070942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.
    Ahlquist DA; Wieand HS; Moertel CG; McGill DB; Loprinzi CL; O'Connell MJ; Mailliard JA; Gerstner JB; Pandya K; Ellefson RD
    JAMA; 1993 Mar; 269(10):1262-7. PubMed ID: 8437303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Faecal occult blood test and mass screening for colorectal cancer].
    Hiwatashi N; Shimada T
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of retesting subjects with a positive Hemoccult in screening for colorectal cancer.
    Kewenter J; Engarås B; Haglind E; Jensen J
    Br J Surg; 1990 Dec; 77(12):1349-51. PubMed ID: 2276015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new screening method for colorectal cancer as a replacement for the hemoccult blood test].
    Sakamoto K; Nagamachi Y; Sugawara I
    Gan No Rinsho; 1990 Jul; 36(8):865-70. PubMed ID: 2366322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal occult blood screening in the Minnesota study: role of chance detection of lesions.
    Ederer F; Church TR; Mandel JS
    J Natl Cancer Inst; 1997 Oct; 89(19):1423-8. PubMed ID: 9326911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia.
    St John DJ; Young GP; McHutchison JG; Deacon MC; Alexeyeff MA
    Ann Intern Med; 1992 Sep; 117(5):376-82. PubMed ID: 1503328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.